Projected Lung Cancer Mortality Rates Among Women By 2030

Henrietta Strickland
August 3, 2018

The study authors concluded that the worldwide lung cancer death rate among women will increase from just over 11 percent in 2015 to 16 percent in 2030. The lowest lung cancer mortality rates in 2030 are projected in America and Asia.

"If we do not implement measures to reduce smoking behaviors in this population, lung cancer mortality will continue to increase throughout the world". Conversely, the breast cancer mortality rate is expected to decrease. Age standardized mortality rates in women for both cancers were reported as per 100,000 person years were calculated for each country based on W.H.O World Standard Population allowing for comparison of countries with different age distributions eliminating age as confounding variable. The project was started by a lung cancer survivor and now acknowledged by health care facilities and communities of people across the globe that has experienced the effects of lung cancer.

Martinez-Sanchez explained that the increase in breast cancer mortality in Asia can be explained by the increasingly Westernized lifestyle, which is associated with two breast cancer risk factors - increased obesity and alcohol intake. There may be greater awareness of breast cancer among Europeans, he suggested, leading to active participation in screening programs and treatment improvements.

"Decades back, lung cancer cases were attributed to smokers and old age groups", said Dr Arvind Kumar, chairman of the SGRH Centre for Chest Surgery, who led the study. To do this, the oncologists examined data from more than 50 countries.

The study was funded by the Portuguese Ministry of Universities and Research, the government of Catalonia, the Italian Association for Research in Cancer, FEDER, and the Foundation for Science and Technology/Portuguese Ministry of Science, Technology and Higher Education.

It is also found that 30% of patients, studied for the report, had been initially misdiagnosed as tuberculosis and were treated for the same for many months before starting cancer treatment.

Martin-Sanchez and co-authors disclosed no relevant relationships with industry.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER